DJYG
PFE icon

David J. Yvars Group’s Pfizer PFE Stock Holding History

David J. Yvars Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-8,348
Closed -$212K – 86
2025
Q1 		$212K Sell
8,348
-742
-8% -$19.4K 0.17% 60
2024
Q4 		$241K Sell
9,090
-913
-9% -$24.8K 0.15% 63
2024
Q3 		$289K Buy
10,003
+49
+0.5% +$1.43K 0.18% 63
2024
Q2 		$279K Buy
+9,954
New +$274K 0.17% 59

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

David J. Yvars Group's PFE Position: Q2 2025 in Review

David J. Yvars Group sold out of Pfizer (PFE) in Q2 2025, closing a stake of 8,348 shares — an estimated $212K sold.

David J. Yvars Group first reported a position in PFE in Q2 2024 and held it in 4 quarters. The position peaked at $289K in Q3 2024. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • David J. Yvars Group reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
  • David J. Yvars Group sold 8,348 Pfizer shares in Q2 2025, an estimated $212K.
  • David J. Yvars Group first reported a position in Pfizer in Q2 2024 and held it in 4 quarters.
  • David J. Yvars Group's Pfizer position peaked at $289K in Q3 2024.
  • 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on David J. Yvars Group's 13F filing for Q2 2025, filed 9 Jul 2025.